Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-01 Option Award | 2026-04-01 5:19 pm | N/A 2036-04-01 | ACTUATE THERAPEUTICS INC. | ACTU | SCHMITT DANIEL M President, CEO and Director | 237,000 | $0 | 237,000 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-01 5:19 pm | N/A 2036-04-01 | ACTUATE THERAPEUTICS INC. | ACTU | Mazar Andrew Paul Chief Operating Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2026-04-01 Option Award | 2026-04-01 5:19 pm | N/A 2036-04-01 | ACTUATE THERAPEUTICS INC. | ACTU | LYTLE PAUL J Chief Financial Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2026-02-13 Exercise | 2026-02-13 6:10 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | SCHMITT DANIEL M President, CEO and Director | 272,055 | $0 | 1,052,977 (Direct) | View |
| 2026-02-13 Tax Withholding | 2026-02-13 6:10 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | SCHMITT DANIEL M President, CEO and Director | 121,874 | $4.33 | 1,052,977 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-23 4:37 pm | N/A 2035-05-22 | ACTUATE THERAPEUTICS INC. | ACTU | THOMSON TODD S Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-23 4:05 pm | N/A 2035-05-22 | ACTUATE THERAPEUTICS INC. | ACTU | Sawhney Roger Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-23 4:05 pm | N/A 2035-05-22 | ACTUATE THERAPEUTICS INC. | ACTU | Zabrowski Dan Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-23 4:05 pm | N/A 2035-05-22 | ACTUATE THERAPEUTICS INC. | ACTU | Fletcher Aaron G.L. Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-23 4:05 pm | N/A 2035-05-22 | ACTUATE THERAPEUTICS INC. | ACTU | Keyes Jason A Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2025-05-22 Option Award | 2025-05-23 4:05 pm | N/A 2035-05-22 | ACTUATE THERAPEUTICS INC. | ACTU | RONNEBERG AMY L Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-02 1:44 pm | N/A 2035-03-31 | ACTUATE THERAPEUTICS INC. | ACTU | SCHMITT DANIEL M President, CEO and Director | 270,788 | $0 | 270,788 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-02 1:43 pm | N/A 2035-03-31 | ACTUATE THERAPEUTICS INC. | ACTU | Mazar Andrew Paul Chief Operating Officer | 161,392 | $0 | 161,392 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-02 1:41 pm | N/A 2035-03-31 | ACTUATE THERAPEUTICS INC. | ACTU | LYTLE PAUL J Chief Financial Officer | 91,293 | $0 | 91,293 (Direct) | View |
| 2024-08-14 Exercise | 2024-08-16 9:12 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | THOMSON TODD S Kairos SPV Fund LLC Kairos Venture Opportunities I L.P. Kairos Venture Partners II L.P. Kairos-Actuate SPV L.P. 16.4% Owner Director | 28,464 | $5.27 | 1,199,795 (Indirect) | View |
| 2024-08-14 Exercise | 2024-08-16 9:12 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | THOMSON TODD S Kairos SPV Fund LLC Kairos Venture Opportunities I L.P. Kairos Venture Partners II L.P. Kairos-Actuate SPV L.P. 16.4% Owner Director | 28,464 | $0 | 1,199,795 (Indirect) | View |
| 2024-08-12 Option Award | 2024-08-16 9:12 pm | N/A 2034-08-12 | ACTUATE THERAPEUTICS INC. | ACTU | THOMSON TODD S Kairos SPV Fund LLC Kairos Venture Opportunities I L.P. Kairos Venture Partners II L.P. Kairos-Actuate SPV L.P. 16.4% Owner Director | 15,000 | $0 | 1,199,795 (Direct) | View |
| 2024-08-14 Conversion | 2024-08-16 9:12 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | THOMSON TODD S Kairos SPV Fund LLC Kairos Venture Opportunities I L.P. Kairos Venture Partners II L.P. Kairos-Actuate SPV L.P. 16.4% Owner Director | 2,577,312 | $0 | 1,199,795 (Indirect) | View |
| 2024-08-14 Exercise | 2024-08-14 8:54 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 37,951 | $5.27 | 216,083 (Indirect) | View |
| 2024-08-14 Exercise | 2024-08-14 8:54 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 37,951 | $0 | 216,083 (Indirect) | View |
| 2024-08-12 Option Award | 2024-08-14 8:54 pm | N/A 2034-08-12 | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 15,000 | $0 | 216,083 (Indirect) | View |
| 2024-08-14 Conversion | 2024-08-14 8:54 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Bios Equity COF LP Bios Clinical Opportunity Fund LP BP Directors LP Director 10% Owner | 9,380,699 | $0 | 216,083 (Indirect) | View |
| 2024-08-14 Exercise | 2024-08-14 8:49 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Fletcher Aaron G.L. BIOS Capital Management LP BIOS Advisors GP LLC BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BIOS Actuate Co-Invest I LP BIOS Actuate Co-Invest II LP Bios Actuate Co-Invest III LP BIOS Equity Partners III LP Director 10% Owner | 37,951 | $5.27 | 216,083 (Indirect) | View |
| 2024-08-14 Exercise | 2024-08-14 8:49 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Fletcher Aaron G.L. BIOS Capital Management LP BIOS Advisors GP LLC BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BIOS Actuate Co-Invest I LP BIOS Actuate Co-Invest II LP Bios Actuate Co-Invest III LP BIOS Equity Partners III LP Director 10% Owner | 37,951 | $0 | 216,083 (Indirect) | View |
| 2024-08-12 Option Award | 2024-08-14 8:49 pm | N/A 2034-08-12 | ACTUATE THERAPEUTICS INC. | ACTU | Fletcher Aaron G.L. BIOS Capital Management LP BIOS Advisors GP LLC BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BIOS Actuate Co-Invest I LP BIOS Actuate Co-Invest II LP Bios Actuate Co-Invest III LP BIOS Equity Partners III LP Director 10% Owner | 15,000 | $0 | 216,083 (Indirect) | View |
| 2024-08-14 Conversion | 2024-08-14 8:49 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Fletcher Aaron G.L. BIOS Capital Management LP BIOS Advisors GP LLC BIOS Fund III LP BIOS Fund III QP LP BIOS Fund III NT LP BIOS Actuate Co-Invest I LP BIOS Actuate Co-Invest II LP Bios Actuate Co-Invest III LP BIOS Equity Partners III LP Director 10% Owner | 9,380,699 | $0 | 216,083 (Indirect) | View |
| 2024-08-14 Exercise | 2024-08-14 8:44 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner | 37,951 | $5.27 | 216,083 (Indirect) | View |
| 2024-08-14 Exercise | 2024-08-14 8:44 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner | 37,951 | $0 | 216,083 (Indirect) | View |
| 2024-08-12 Option Award | 2024-08-14 8:44 pm | N/A 2034-08-12 | ACTUATE THERAPEUTICS INC. | ACTU | Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner | 15,000 | $0 | 216,083 (Indirect) | View |
| 2024-08-14 Conversion | 2024-08-14 8:44 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Kreis Leslie W. Cavu Advisors LLC Cavu Management LP BIOS Fund I LP BIOS Fund I QP LP Bios Equity Partners LP BIOS Fund II LP BIOS Fund II NT LP BIOS Fund II QP LP Bios Equity Partners II LP 10% Owner | 9,380,699 | $0 | 216,083 (Indirect) | View |
Ownership | 2024-08-14 7:48 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Bios 2024 Co-Invest LP Member of 10% Group Director | 0 | $0 | 125,000 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 7:30 pm | N/A 2034-08-12 | ACTUATE THERAPEUTICS INC. | ACTU | Zabrowski Dan Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2024-08-14 Option Award | 2024-08-14 7:29 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | SCHMITT DANIEL M President, CEO and Director | 544,111 | $0 | 0 (Direct) | View |
| 2024-08-14 Option Award | 2024-08-14 7:28 pm | N/A 2034-08-14 | ACTUATE THERAPEUTICS INC. | ACTU | LYTLE PAUL J Chief Financial Officer | 234,971 | $0 | 0 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 7:27 pm | N/A 2034-08-12 | ACTUATE THERAPEUTICS INC. | ACTU | Keyes Jason A Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 7:26 pm | N/A 2034-08-12 | ACTUATE THERAPEUTICS INC. | ACTU | RONNEBERG AMY L Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-14 7:25 pm | N/A 2034-08-12 | ACTUATE THERAPEUTICS INC. | ACTU | Sawhney Roger Director | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2024-08-12 9:49 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Zabrowski Dan Director | 0 | $0 | 92,290 (Indirect) | View |
Ownership | 2024-08-12 9:48 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | SCHMITT DANIEL M President, CEO and Director | 0 | $0 | 630,740 (Indirect) | View |
Ownership | 2024-08-12 9:47 pm | N/A N/A | ACTUATE THERAPEUTICS INC. | ACTU | Mazar Andrew Paul Chief Operating Officer | 0 | $0 | 164,624 (Direct) | View |